Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent
2024

New Enzyme from Seaweed May Help Control Diabetes

publication 10 minutes Evidence: moderate

Author Information

Author(s): Gajanayaka Navindu Dinara, Jo Eunyoung, Bandara Minthari Sakethanika, Marasinghe Svini Dileepa, Bawkar Chinmayee, Lee Yeon-Ju, Park Gun-Hoo, Oh Chulhong, Lee Youngdeuk

Primary Institution: Korea Institute of Ocean Science and Technology

Hypothesis

Can a novel ulvan lyase from Pseudoalteromonas agarivorans be characterized for its potential as an anti-diabetic agent?

Conclusion

The novel ulvan lyase PaUL25 shows promise as an anti-diabetic agent by inhibiting alpha-glucosidase activity.

Supporting Evidence

  • PaUL25 exhibited optimal activity at pH 10 and 35 °C.
  • Enzyme activity was enhanced by more than 150% in the presence of Mn2+.
  • Partially and completely hydrolysed ulvan oligosaccharides showed significant alpha-glucosidase inhibitory activity.

Takeaway

Scientists found a new enzyme from seaweed that can help lower blood sugar levels, which is good for people with diabetes.

Methodology

The study involved biochemical characterization of the ulvan lyase PaUL25, including its activity at different temperatures and pH levels, and its ability to inhibit alpha-glucosidase.

Limitations

The study primarily focuses on in vitro results, and further in vivo studies are needed to confirm the findings.

Statistical Information

P-Value

2.51 mg/mL and 3.21 mg/mL for completely and partially hydrolysed ulvan respectively

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/md22120577

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication